Moyaert J, Gilles A, Mertens G, Lammers M, Gommeren H, Janssens de Varebeke S
Sci Rep. 2024; 14(1):184.
PMID: 38167558
PMC: 10762206.
DOI: 10.1038/s41598-023-50583-6.
Robijn S, Smits J, Sezer K, Huygen P, Beynon A, van Wijk E
Biomolecules. 2022; 12(2).
PMID: 35204720
PMC: 8961530.
DOI: 10.3390/biom12020220.
Aladham Y, Ahmed O, Hassan S, Francis-Khoury E
J Surg Case Rep. 2021; 2021(1):rjaa592.
PMID: 33532052
PMC: 7837340.
DOI: 10.1093/jscr/rjaa592.
Ocak E, Duman D, Tekin M
Balkan Med J. 2019; 36(4):206-211.
PMID: 31131597
PMC: 6636654.
DOI: 10.4274/balkanmedj.galenos.2019.2019.4.66.
JanssensdeVarebeke S, Topsakal V, Van Camp G, Van Rompaey V
Eur Arch Otorhinolaryngol. 2019; 276(5):1251-1262.
PMID: 30806805
DOI: 10.1007/s00405-019-05322-x.
Identification of a rare COCH mutation by whole-exome sequencing : Implications for personalized therapeutic rehabilitation in an Austrian family with non-syndromic autosomal dominant late-onset hearing loss.
Parzefall T, Frohne A, Koenighofer M, Kirchnawy A, Streubel B, Schoefer C
Wien Klin Wochenschr. 2017; 130(9-10):299-306.
PMID: 28733840
PMC: 5966484.
DOI: 10.1007/s00508-017-1230-y.
[Dehiscence syndromes : Diagnosis and treatment].
Ernst A, Todt I, Wagner J
HNO. 2016; 64(11):790-796.
PMID: 27742966
DOI: 10.1007/s00106-016-0255-2.
Identification of pathogenic mechanisms of COCH mutations, abolished cochlin secretion, and intracellular aggregate formation: genotype-phenotype correlations in DFNA9 deafness and vestibular disorder.
Bae S, Robertson N, Cho H, Morton C, Jung D, Baek J
Hum Mutat. 2014; 35(12):1506-1513.
PMID: 25230692
PMC: 4373469.
DOI: 10.1002/humu.22701.
Dehiscence of the superior semicircular canal: a review of the literature on its possible pathogenic explanations.
Brandolini C, Modugno G, Pirodda A
Eur Arch Otorhinolaryngol. 2013; 271(3):435-7.
PMID: 23595618
DOI: 10.1007/s00405-013-2497-x.
A novel COCH mutation associated with autosomal dominant nonsyndromic hearing loss disrupts the structural stability of the vWFA2 domain.
Cho H, Park H, Trexler M, Venselaar H, Lee K, Robertson N
J Mol Med (Berl). 2012; 90(11):1321-1331.
PMID: 22610276
PMC: 4361775.
DOI: 10.1007/s00109-012-0911-2.
Perspectives in vestibular diagnostics and therapy.
Ernst A
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2012; 10:Doc05.
PMID: 22558055
PMC: 3341582.
DOI: 10.3205/cto000078.
DFNA8/12 caused by TECTA mutations is the most identified subtype of nonsyndromic autosomal dominant hearing loss.
Hildebrand M, Morin M, Meyer N, Mayo F, Modamio-Hoybjor S, Mencia A
Hum Mutat. 2011; 32(7):825-34.
PMID: 21520338
PMC: 3326665.
DOI: 10.1002/humu.21512.
Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing.
Shearer A, DeLuca A, Hildebrand M, Taylor K, Gurrola 2nd J, Scherer S
Proc Natl Acad Sci U S A. 2010; 107(49):21104-9.
PMID: 21078986
PMC: 3000272.
DOI: 10.1073/pnas.1012989107.
A novel mutation in COCH-implications for genotype-phenotype correlations in DFNA9 hearing loss.
Hildebrand M, Gandolfo L, Shearer A, Webster J, Jensen M, Kimberling W
Laryngoscope. 2010; 120(12):2489-93.
PMID: 21046548
PMC: 3329724.
DOI: 10.1002/lary.21159.
A contemporary review of AudioGene audioprofiling: a machine-based candidate gene prediction tool for autosomal dominant nonsyndromic hearing loss.
Hildebrand M, DeLuca A, Taylor K, Hoskinson D, Hur I, Tack D
Laryngoscope. 2009; 119(11):2211-5.
PMID: 19780026
PMC: 2783729.
DOI: 10.1002/lary.20664.